Human NK cell repertoire diversity reflects immune experience and correlates with viral susceptibility

Science Translational Medicine

Volumn 7, Issue 297, 2015, Pages

  Strauss Albee, Dara M ^a   Fukuyama, Julia ^b   Liang, Emily C ^a   Yao, Yi ^c   Jarrell, Justin A ^a   Drake, Alison L ^d   Kinuthia, John ^e   Montgomery, Ruth R ^c   John Stewart, Grace ^d,f   Holmes, Susan ^b   Blish, Catherine A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e KENYATTA NATIONAL HOSPITAL   (Kenya)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL DIVISION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEGRANULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; INFECTION RISK; INFECTION SENSITIVITY; LYMPHOCYTE DIFFERENTIATION; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; VIRUS INFECTION; WEST NILE VIRUS; ADULT; BIOSYNTHESIS; DISEASE PREDISPOSITION; DONOR; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; IMMUNOLOGY; KENYA; VIROLOGY;

CYTOKINE;

ADULT; CYTOKINES; DISEASE SUSCEPTIBILITY; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY; KENYA; KILLER CELLS, NATURAL; TISSUE DONORS;

EID: 84937923776     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aac5722     Document Type: Article

References (48)

1. E. Rechavi, A. Lev, Y. N. Lee, A. J. Simon, Y. Yinon, S. Lipitz, N. Amariglio, B. Weisz, L. D. Notarangelo, R. Somech, Timely and spatially regulated maturation of B and T cell repertoire during human fetal development. Sci. Transl. Med. 7, 276ra25 (2015).
2. L. Garderet, N. Dulphy, C. Douay, N. Chalumeau, V. Schaeffer, M.-T. Zilber, A. Lim, J. Even, N. Mooney, C. Gelin, E. Gluckman, D. Charron, A. Toubert, The umbilical cord blood αβ T-cell repertoire: Characteristics of a polyclonal and naive but completely formed repertoire. Blood 91, 340-346 (1998).
3. S. Shiokawa, F. Mortari, J. O. Lima, C. Nuñez, F. E. Bertrand III, P. M. Kirkham, S. Zhu, A. P. Dasanayake, H. W. Schroeder, IgM heavy chain complementarity-determining region 3 diversity is constrained by genetic and somatic mechanisms until two months after birth. J. Immunol. 162, 6060-6070 (1999).
4. H. W. Schroeder Jr., L. Zhang, J. B. Philips III, Slow, programmed maturation of the immunoglobulin HCDR3 repertoire during the third trimester of fetal life. Blood 98, 2745-2751 (2001).
5. A. Horowitz, D. M. Strauss-Albee, M. Leipold, J. Kubo, N. Nemat-Gorgani, O. C. Dogan, C. L. Dekker, S. Mackey, H. Maecker, G. E. Swan, M. M. Davis, P. J. Norman, L. A. Guethlein, M. Desai, P. Parham, C. A. Blish, Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry. Sci. Transl. Med. 5, 208ra145 (2013).
6. D. M. Strauss-Albee, A. Horowitz, P. Parham, C. A. Blish, Coordinated regulation of NK receptor expression in the maturing human immune system. J. Immunol. 193, 4871-4879 (2014).
7. L. L. Lanier, NK cell recognition. Annu. Rev. Immunol. 23, 225-274 (2005).
8. J. S. Orange, Natural killer cell deficiency. J. Allergy Clin. Immunol. 132, 515-525 (2013).
9. E. Vivier, E. Tomasello, M. Baratin, T. Walzer, S. Ugolini, Functions of natural killer cells. Nat. Immunol. 9, 503-510 (2008).
10. + NK cells respond specifically to acute infection with cytomegalovirus and not Epstein-Barr virus. J. Immunol. 192, 4492-4496 (2014).
11. 2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D. Science 341, 186-191 (2013).
12. hinatural killer cell subset during acute human cytomegalovirus infection. Proc. Natl. Acad. Sci. U.S.A. 108, 14725-14732 (2011).
13. M. S. Diamond, B. Shrestha, E. Mehlhop, E. Sitati, M. Engle, Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus. Viral Immunol. 16, 259-278 (2003).
14. S. Jost, M. Altfeld, Control of human viral infections by natural killer cells. Annu. Rev. Immunol. 31, 163-194 (2013).
15. G. Alter, M. Altfeld, NK cells in HIV-1 infection: Evidence for their role in the control of HIV-1 infection. J. Intern. Med. 265,29-42 (2009).
16. M. P. Martin, Y. Qi, X. Gao, E. Yamada, J. N. Martin, F. Pereyra, S. Colombo, E. E. Brown, W. L. Shupert, J. Phair, J. J. Goedert, S. Buchbinder, G. D. Kirk, A. Telenti, M. Connors, S. J. O'Brien, B. D. Walker, P. Parham, S. G. Deeks, D. W. McVicar, M. Carrington, Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat. Genet. 39,733-740 (2007).
17. H. Fausther-Bovendo, N. Sol-Foulon, D. Candotti, H. Agut, O. Schwartz, P. Debré, V. Vieillard, HIV escape from natural killer cytotoxicity: Nef inhibits NKp44L expression on CD4+ T cells. AIDS 23, 1077-1087 (2009).
18. A. H. Shah, B. Sowrirajan, Z. B. Davis, J. P. Ward, E. M. Campbell, V. Planelles, E. Barker, Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu. Cell Host Microbe 8,397-409 (2010).
19. G. Matusali, M. Potesta, A. Santoni, C. Cerboni, M. Doria, The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR. J. Virol. 86, 4496-4504 (2012).
20. V. Naranbhai, S. S. Abdool Karim, M. Altfeld, N. Samsunder, R. Durgiah, S. Sibeko, Q. Abdool Karim, W. H. Carr; CAPRISA004 TRAPS team, Innate immune activation enhances HIV acquisition in women, diminishing the effectiveness of tenofovir microbicide gel. J. Infect. Dis. 206, 993-1001 (2012).
21. D. Scott-Algara, L. X. Truong, P. Versmisse, A. David, T. T. Luong, N. V. Nguyen, I. Theodorou, F. Barré-Sinoussi, G. Pancino, Cutting edge: Increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users. J. Immunol. 171, 5663-5667 (2003).
22. V. Naranbhai, M. Altfeld, Q. Abdool Karim, T. Ndung'u, S. S. Abdool Karim, W. H. Carr; Centre for the AIDS Programme of Research in South Africa (CAPRISA) Tenofovir gel Research for AIDS Prevention Science (TRAPS) Team, Natural killer cell function in women at high risk for HIV acquisition: Insights from a microbicide trial. AIDS 26, 1745-1753 (2012).
23. Y. Zhang, D. L. Wallace, C. M. De Lara, H. Ghattas, B. Asquith, A. Worth, G. E. Griffin, G. P. Taylor, D. F. Tough, P. C. L. Beverley, D. C. Macallan, In vivo kinetics of human natural killer cells: The effects of ageing and acute and chronic viral infection. Immunology 121,258-265 (2007).
24. A. M. Jamieson, P. Isnard, J. R. Dorfman, M. C. Coles, D. H. Raulet, Turnover and proliferation of NK cells in steady state and lymphopenic conditions. J. Immunol. 172, 864-870 (2004).
25. N. A. Bezman, C. C. Kim, J. C. Sun, G. Min-Oo, D. W. Hendricks, Y. Kamimura, J. A. Best, A. W. Goldrath, L. L. Lanier; The Immunological Genome Project Consortium, Molecular definition of the identity and activation of natural killer cells. Nat. Immunol. 13, 1000-1009 (2012).
26. J. Brady, S. Carotta, R. P. L. Thong, C. J. Chan, Y. Hayakawa, M. J. Smyth, S. L. Nutt, The interactions of multiple cytokines control NK cell maturation. J. Immunol. 185, 6679-6688 (2010).
27. C. de Rham, S. Ferrari-Lacraz, S. Jendly, G. Schneiter, J.-M. Dayer, J. Villard, The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors. Arthritis Res. Ther. 9, R125 (2007).
28. + NK-cell subset. Blood 116, 3865-3874 (2010).
29. M. Le Garff-Tavernier, V. Béziat, J. Decocq, V. Siguret, F. Gandjbakhch, E. Pautas, P. Debré, H. Merle-Beral, V. Vieillard, Human NK cells display major phenotypic and functional changes over the life span. Aging Cell 9, 527-535 (2010).
30. J. Kinuthia, A. L. Drake, D. Matemo, B. A. Richardson, C. Zeh, L. Osborn, J. Overbaugh, R. S. McClelland, G. JohnStewart, HIV acquisition during pregnancy and postpartum is associated with genital infections and partnership characteristics: A cohort study. AIDS, in press.
31. G. K. Behbehani, S. C. Bendall, M. R. Clutter, W. J. Fantl, G. P. Nolan, Single-cell mass cytometry adapted to measurements of the cell cycle. Cytometry A 81, 552-566 (2012).
32. L. R. Petersen, P. J. Carson, B. J. Biggerstaff, B. Custer, S. M. Borchardt, M. P. Busch, Estimated cumulative incidence of West Nile virus infection in US adults, 1999-2010. Epidemiol. Infect. 141, 591-595 (2013).
33. M. Zhang, S. Daniel, Y. Huang, C. Chancey, Q. Huang, Y. F. Lei, A. Grinev, H. Mostowski, M. Rios, A. Dayton, Anti-West Nile virus activity of in vitro expanded human primary natural killer cells. BMC Immunol. 11, 3 (2010).
34. J. Nikolich-Žugich, M. K. Slifka, I. Messaoudi, The many important facets of T-cell repertoire diversity. Nat. Rev. Immunol. 4, 123-132 (2004).
35. R. Schwab, P. Szabo, J. S. Manavalan, M. E. Weksler, D. N. Posnett, C. Pannetier, P. Kourilsky, J. Even, Expanded CD4+ and CD8+ T cell clones in elderly humans. J. Immunol. 158, 4493-4499 (1997).
36. K. Naylor, G. Li, A. N. Vallejo, W.-W. Lee, K. Koetz, E. Bryl, J. Witkowski, J. Fulbright, C. M. Weyand, J. J. Goronzy, The influence of age on T cell generation and TCR diversity. J. Immunol. 174, 7446-7452 (2005).
37. N. Jiang, J. He, J. A. Weinstein, L. Penland, S. Sasaki, X.-S. He, C. L. Dekker, N.-Y. Zheng, M. Huang, M. Sullivan, P. C. Wilson, H. B. Greenberg, M. M. Davis, D. S. Fisher, S. R. Quake, Lineage structure of the human antibody repertoire in response to influenza vaccination. Sci. Transl. Med. 5, 171ra19 (2013).
38. R. A. Kyle, T. M. Therneau, S. V. Rajkumar, D. R. Larson, M. F. Plevak, J. R. Offord, A. Dispenzieri, J. A. Katzmann, L. J. Melton III, Prevalence of monoclonal gammopathy of undetermined significance. N. Engl. J. Med. 354, 1362-1369 (2006).
39. T. Nabekura, L. L. Lanier, Antigen-specific expansion and differentiation of natural killer cells by alloantigen stimulation. J. Exp. Med. 211, 2455-2465 (2014).
40. C. R. Wira, M. Rodriguez-Garcia, M. V. Patel, The role of sex hormones in immune protection of the female reproductive tract. Nat. Rev. Immunol. 15, 217-230 (2015).
41. A. Iwasaki, Antiviral immune responses in the genital tract: Clues for vaccines. Nat. Rev. Immunol. 10, 699-711 (2010).
42. S. C. Bendall, E. F. Simonds, P. Qiu, E. A. D. Amir, P. O. Krutzik, R. Finck, R. V. Bruggner, R. Melamed, A. Trejo, O. I. Ornatsky, R. S. Balderas, S. K. Plevritis, K. Sachs, D. Pe'er, S. D. Tanner, G. P. Nolan, Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 332, 687-696 (2011).
43. + T cell phenotypes. Immunity 36, 142-152 (2012).
44. H. G. Fienberg, E. F. Simonds, W. J. Fantl, G. P. Nolan, B. Bodenmiller, A platinum-based covalent viability reagent for single-cell mass cytometry. Cytometry A 81, 467-475 (2012).
45. N. M. Provine, W. B. Puryear, X. Wu, J. Overbaugh, N. L. Haigwood, The infectious molecular clone and pseudotyped virus models of human immunodeficiency virus type 1 exhibit significant differences in virion composition with only moderate differences in infectivity and inhibition sensitivity. J. Virol. 83, 9002-9007 (2009).
46. F. Qian, G. Goel, H. Meng, X. Wang, F. You, L. Devine, K. Raddassi, M. N. Garcia, K. O. Murray, C. R. Bolen, R. Gaujoux, S. S. Shen-Orr, D. Hafler, E. Fikrig, R. Xavier, S. H. Kleinstein, R. R. Montgomery, Systems immunology reveals markers of susceptibility to West Nile virus infection. Clin. Vaccine Immunol. 22, 6-16 (2015).
47. R. Finck, E. F. Simonds, A. Jager, S. Krishnaswamy, K. Sachs, W. Fantl, D. Pe'er, G. P. Nolan, S. C. Bendall, Normalization of mass cytometry data with bead standards. Cytometry A 83, 483-494 (2013).
48. R. V. Bruggner, B. Bodenmiller, D. L. Dill, R. J. Tibshirani, G. P. Nolan, Automated identification of stratifying signatures in cellular subpopulations. Proc. Natl. Acad. Sci. U.S.A. 111, E2770-E2777 (2014).